Zoran Zdraveski
CIK: 0001741285
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TScan Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Oct 1, 2026TCRX
TScan Therapeutics, Inc.
Award(A)Direct300K shares- - Jan 20, 2026TCRX
TScan Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
350K shares- - Jan 3, 2025TCRX
TScan Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
250K shares- - Jan 12, 2024TCRX
TScan Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
52.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | TCRX TScan Therapeutics, Inc. | Award(A) | 300,000 | - | $0 | Direct |
| Jan 20, 2026 | TCRX TScan Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 350,000 | - | - | Direct |
| Jan 3, 2025 | TCRX TScan Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 250,000 | - | - | Direct |
| Jan 12, 2024 | TCRX TScan Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 52,500 | - | - | Direct |
1-4 of 4 transactions
About ZDRAVESKI ZORAN
ZDRAVESKI ZORAN (SEC CIK 0001741285) files insider reports with the SEC as Officer of TScan Therapeutics, Inc. (TCRX).
Signal8 holds 3 ownership filings by ZDRAVESKI ZORAN, all Form 4s, filed between Feb 11, 2025 and Oct 2, 2026. Those filings report 4 transactions, from Jan 12, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ZDRAVESKI ZORAN's filings is in WALTHAM, MA.
Recent filings by ZDRAVESKI ZORAN
Other insiders filing for TScan Therapeutics, Inc. (TCRX)
- MacBeath Gavin, Chief Executive Officer
- BAKER BROS. ADVISORS LP, Director
- Woods Keith, Director
- Nicholson Garry A, Director
- Gruia Gabriela, Director
- Dorton Katina, Director